Author: Mike Vodicka

November 3 is a big day for the U.S. cannabis industry. Five U.S. states will vote on measures to legalize medical or recreational cannabis.

Leading cannabis market research firm New Frontier Data’s new research report projects that the vote will have a big impact on U.S. cannabis sales.

“The 2020 election could be one of the most consequential and historical events to change the landscape of the legal U.S. cannabis industry,” said New Frontier Data Founder & CEO Giadha A. DeCarcer. “With $9 billion in new revenue from 2022-2025, should all five states ballot measures pass, New Frontier Data estimates that revenues from all legal U.S. markets will reach $35.1B in 2025.”

From the group of five U.S. states getting ready to vote on legalization, none is more important than New Jersey for two reasons. Continue reading “3 Early Leaders Ready to Cash in if New Jersey Goes Legal on November 3” →

Back in 2019, Aurora Cannabis was the rock star of the cannabis industry. At its peak, Aurora nabbed a market cap of $10 billion.

The company had delivered enormous gains to early investors. It also and ranked as the #1 held stock on the popular stock trading app, Robinhood.

The enthusiasm was driven by Aurora’s impressive portfolio of cannabis businesses and assets.

That portfolio included 15 global cannabis cultivation centers capable of producing more than 700,000 kilograms of cannabis per year. Aurora had also secured exclusive cannabis permits in potentially lucrative international markets including Germany and Australia. Aurora invested hundreds of millions to build an unparalleled global cannabis production and distribution network.

However, customers never showed up. Continue reading “2 Reasons to Avoid Aurora Cannabis” →

Cannabis investors looking for the next big thing need to take a look at psychedelic stocks. Not only is the industry growing rapidly, but a promising young biotech, led by a Facebook billionaire, just filed to go public.

Hot on the heels of cannabis, psychedelic mushrooms are quickly gaining credibility for their medicinal value.

Researchers and users are discovering that psilocybin, the psychedelic compound found in “magic mushrooms,” can be a highly effective treatment for depression.

This information is giving birth to a new industry, psychedelic pharmaceutical drugs. Analysts expect this industry to grow sharply in the coming years. Continue reading “Invest in Magic Mushrooms with a $100 Million IPO” →

Like many other states, the Pennsylvania economy has been wounded by COVD-19. However, the governor has a solution to repair some of the damage – legalize cannabis.

On Tuesday, Pennsylvania governor Tom Wolf (D) announced that legalizing recreational cannabis is a high priority on his fall legislative agenda. Continue reading “Pennsylvania’s COVID Recovery Plan Includes Cannabis” →

I see two powerful catalysts directly on the horizon for cannabis stocks and an elite group of cannabis stocks are already starting to take off. For anyone who does not already own these stocks, there is still time to get in. Continue reading “2020 U.S. Election is Massive Catalyst for Cannabis Stocks” →